Heterosubtypic immunity to H7N9 influenza virus in isogenic guinea pigs after infection with pandemic H1N1 virus

Vaccine
Lidewij C M WiersmaG F Rimmelzwaan

Abstract

Heterosubtypic immunity is defined as immune-mediated (partial) protection against an influenza virus induced by an influenza virus of another subtype to which the host has not previously been exposed. This cross-protective effect has not yet been demonstrated to the newly emerging avian influenza A viruses of the H7N9 subtype. Here, we assessed the induction of protective immunity to these viruses by infection with A(H1N1)pdm09 virus in a newly developed guinea pig model. To this end, ten female 12-16 week old strain 2 guinea pigs were inoculated intratracheally with either A(H1N1)pdm09 influenza virus or PBS (unprimed controls) followed 4 weeks later with an A/H7N9 influenza virus challenge. Nasal swabs were taken daily and animals from both groups were sacrificed on days 2 and 7 post inoculation (p.i.) with A/H7N9 virus and full necropsies were performed. Nasal virus excretion persisted until day 7 in unprimed control animals, whereas only two out of seven H1N1pdm09-primed animals excreted virus via the nose. Infectious virus was recovered from nasal turbinates, trachea and lung of all animals at day 2 p.i., but titers were lower for H1N1pdm09-primed animals, especially in the nasal turbinates. By day 7 p.i., relatively high...Continue Reading

References

Jul 7, 1983·The New England Journal of Medicine·A J McMichaelP A Beare
Jul 25, 2006·Vaccine·Timothy M StraightMaryna C Eichelberger
Jul 30, 2008·Microbes and Infection·Kristie M GrebeJack R Bennink
May 9, 2009·The New England Journal of Medicine·Fatimah S DawoodTimothy M Uyeki
Mar 2, 2010·Journal of the American Society for Mass Spectrometry·Tomas Baer, Robert C Dunbar
Mar 3, 2011·Journal of Internal Medicine·K K McKinstryS L Swain
Oct 23, 2012·The Journal of Infectious Diseases·Matthew S MillerPeter Palese
Jul 28, 2013·The Lancet Infectious Diseases·Guus F RimmelzwaanAlbert D M E Osterhaus
Aug 28, 2013·Current Opinion in Virology·Florian Krammer, Peter Palese
Sep 24, 2013·Nature Medicine·Saranya SridharAjit Lalvani

❮ Previous
Next ❯

Citations

Jan 21, 2018·Frontiers of Medicine·Simone NüssingKatherine Kedzierska

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.